Internal Medicine News‘Surprising’ lack of benefit to adding palbociclib to endocrine therapy in early HR+/HER2– breast cancerDecember 13, 2021Breast Cancer
Internal Medicine NewsMyeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesHematology
Internal Medicine NewsFor leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021COVID-19 UpdatesCritical CareHematology
Internal Medicine NewsBeta-thalassemia gene therapy achieves lasting transfusion independenceDecember 11, 2021HematologyAnemia
Internal Medicine NewsThe evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapiesDecember 11, 2021Breast Cancer
Internal Medicine NewsLiver cancer risk lingers even after HCV eradicationDecember 10, 2021HepatologyGastroenterologyOncology
Internal Medicine NewsBullying a ‘persistent, important’ problem for cardiology traineesDecember 10, 2021Business of Medicine
Internal Medicine NewsGenomic instability varies between breast cancer subtypesDecember 10, 2021Oncology
Internal Medicine NewsOngoing HER2 breast cancer therapy may cost an additional $68,000 per patientDecember 10, 2021OncologyBreast Cancer
Internal Medicine NewsVitamin D counters bone density loss with aromatase inhibitorsDecember 10, 2021OncologyBreast Cancer
Internal Medicine NewsMetformin does not improve outcomes in early breast cancerDecember 10, 2021OncologyBreast Cancer
Internal Medicine NewsUpdated ACG GERD guideline addresses increased scrutiny of PPI therapyDecember 10, 2021Gastroenterology
